Join to view full profile
800 Washington StBoston, MA 02111
Phone+1 617-636-5000
Dr. Comenzo is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1989 - 1992
Boston University Medical CenterResidency, Internal Medicine, 1986 - 1989
Boston University School of MedicineClass of 1986
Certifications & Licensure
MA State Medical License 1988 - 2027
NY State Medical License 1998 - 2010
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
American Board of Pathology Blood Banking/Transfusion Medicine
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- Boston Magazine Castle Connolly, 2009-2013
- America's Top Doctors for Cancer Castle Connolly, 2009-2013
Clinical Trials
Publications & Presentations
PubMed
- Ixazomib maintenance for the treatment of light chain AL amyloidosis.Caitlin Sarubbi, Hani Hassoun, Grace Gallagher, Mithat Gonen, Eugene Brailovski
Amyloid. 2026-10-29 - 1 citationsSusceptibility and screening approaches in systemic amyloidosis: expert perspectives from the International Society of Amyloidosis (ISA).Taxiarchis Kourelis, Raymond Comenzo, Andrea Cortese, Justin L Grodin, Martha Grogan
Amyloid. 2026-09-04 - Diagnostic Accuracy of Fat Pad Sampling and Bone Marrow Biopsy for AL Amyloidosis: A Systematic Review and Meta-Analysis.Muayad Azzam, Hassan Kawtharany, Jamil Nazzal, Qais Hamarsha, Aseel Alkhader
Blood Advances. 2026-09-04
Abstracts/Posters
- In Systemic Light-Chain Amyloidosis Complete and Very Good Partial Responses Are Not Enough: Involved Free Light Chain (iFLC) Levels < 10mg/L Are Associated with Optim...Raymond L Comenzo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- B-Cell Maturation Antigen (BCMA) in Systemic Light-Chain Amyloidosis (AL): Association with Disease Activity and Its Modulation with Gamma-Secretase InhibitionRaymond L Comenzo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Primary Results from the Phase 3 Tourmaline-AL1 Trial of Ixazomib-Dexamethasone Versus PhysicianÍs Choice of Therapy in Patients (Pts) with Relapsed/Refractory Primary...Raymond L Comenzo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Untangling Amyloidosis 201961st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Seeking AL Amyloidosis Very Early: The SAVE Trial - Identifying Clonal Lambda Light Chain Genes in Patients with MGUS or Smoldering Multiple Myeloma2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
What Is Causing the National Blood Shortage?March 4th, 2022- What Doctors Want You to Know About the Potential Link Between COVID-19 and Blood TypeJune 24th, 2020
Experimental Drug Shows Promise for Rare Genetic Disorder – WebMDFebruary 11th, 2019
Grant Support
- Screening for AL Amyloidosis in Smoldering Multiple MyelomaTUFTS MEDICAL CENTER2024–2029
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: